ROMTech Wins Newsweek Award for AI Remote Patient Monitoring
Oct 14, 2026
Analyst and Vendor Research
Recor Medical Reports 19.6 mmHg Blood Pressure Reduction with Paradise System in Six Months
Nov 4, 2025
Recor Medical and Otsuka Medical Devices announced clinical data showing a 19.6 mmHg blood pressure reduction after six months using the Paradise renal denervation system, presented at the TCT 2025 conference.
Recor Medical and its parent company Otsuka Medical Devices announced in a press release that new real-world clinical data presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference demonstrated a significant blood pressure reduction using the Paradise System for renal denervation.
According to the results from the Global Paradise System (GPS) registry, patients experienced a 19.6 mmHg decrease in systolic office blood pressure after six months of treatment with the ultrasound-based Paradise system. The analysis of pooled data from the global RADIANCE study program also showed a sustained systolic blood pressure reduction of 15.7 mmHg after 24 months.
The Paradise uRDN system is a device-based adjunctive therapy for patients with uncontrolled or resistant hypertension whose blood pressure remains high despite lifestyle modifications and medication.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Masimo Gets FDA Clearance for AFib Detection on Radius VSM
Oct 17, 2026
Healthcare
Laza Medical raises up to $160 million for cardiac imaging system
Nov 04, 2026
Funding
FDA Clears RIVANNA BoneEnhance Software for Accuro XV
Oct 22, 2026
Healthcare
Limber Health Introduces 90 Day Recovery Forecast for Rehab Therapy
Oct 21, 2026
Healthcare
Coreline Soft Receives FDA Clearance for Aortic CT Analysis Software
Oct 23, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.